1. Home
  2. TWST vs LGND Comparison

TWST vs LGND Comparison

Compare TWST & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$44.49

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$195.24

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWST
LGND
Founded
2013
1987
Country
United States
United States
Employees
N/A
68
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.7B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
TWST
LGND
Price
$44.49
$195.24
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$48.75
$245.86
AVG Volume (30 Days)
903.2K
183.6K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
63.89
N/A
EPS
N/A
N/A
Revenue
$376,572,000.00
N/A
Revenue This Year
$18.91
$1.50
Revenue Next Year
$15.07
$18.28
P/E Ratio
N/A
$76.27
Revenue Growth
20.32
N/A
52 Week Low
$23.30
$93.58
52 Week High
$57.88
$227.92

Technical Indicators

Market Signals
Indicator
TWST
LGND
Relative Strength Index (RSI) 46.04 44.28
Support Level $41.65 $179.55
Resistance Level $45.76 $207.72
Average True Range (ATR) 2.66 10.02
MACD -0.06 -1.59
Stochastic Oscillator 26.56 3.39

Price Performance

Historical Comparison
TWST
LGND

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: